1 / 21

New Standards of Care in ALK -Translocated Advanced NSCLC

New Standards of Care in ALK -Translocated Advanced NSCLC.

garrett-herrera
Télécharger la présentation

New Standards of Care in ALK -Translocated Advanced NSCLC

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. New Standards of Care in ALK-Translocated Advanced NSCLC

  2. This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States, and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.

  3. Information Needed in Advanced NSCLC

  4. Genetic Testing Techniques

  5. ALK Translocations

  6. A Newly Diagnosed Patient Case

  7. Summary of Recent Clinical Trials

  8. Ongoing Front-Line Clinical Trials

  9. Faculty Experience With Alectinib Toxicities

  10. Faculty Experience With Ceritinib Toxicities

  11. Faculty Experience With Brigatinib Toxicities

  12. Faculty Experience With Lorlatinib Toxicities

  13. A Patient Who Received First-Line Crizotinib

  14. Summary of Trials in Crizotinib-Refractory ALK-Positive NSCLC

  15. A Patient Who Received Front-Line Alectinib

  16. A Role for Immunotherapy?

  17. IMPower150

  18. Faculty Treatment Recommendations

  19. Abbreviations

  20. Abbreviations (cont)

More Related